Drug Shortage Report for OXALIPLATIN
| Report ID | 19750 |
| Drug Identification Number | 02444763 |
| Brand name | OXALIPLATIN |
| Common or Proper name | Oxaliplatin |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | OXALIPLATIN |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1x20mL |
| ATC code | L01XA |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2017-09-30 |
| Actual start date | |
| Estimated end date | 2017-10-31 |
| Actual end date | 2017-09-20 |
| Shortage status | Avoided shortage |
| Updated date | 2017-09-29 |
| Company comments | Other format available: OXALIPLATIN 5mg/mL 1x10mL OGVL |
| Health Canada comments | |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.